Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Article in English | MEDLINE | ID: mdl-35162275

ABSTRACT

Gauging the social relationships of the elderly is a significant sociometric research subject and a deep biomedical concern-particularly after the COVID-19 pandemic. It is imperative for facultatives in primary care, for geriatric clinics, and for social care services. In this respect, this article explores the validity of an abbreviated version of the Sociotype Questionnaire (SOCQ), a tool previously developed by the authors for assessing the social relationships of the general population, now specifically addressed to the elderly population. The aim is to construct a 4-item dichotomous scale (SOCG-4) out of the 12 items of the original scale of the SOCQ, so that it can serve to discriminate among the patients in primary care and the geriatric clinic, helping the facultative to find those in need of social care or of psychosocial intervention. The population data have been obtained from a series of previous studies on social relationships in different segments of the elderly population (Ntotal = 915). The resulting abbreviated version of SOCG-4 was extracted by means of confirmatory factor analysis, with the congruence, validity, and relationship with the determinants as close to optimal. The significant correlations with SOCQ (0.82), UCLA (-0.55), Barthel (0.40), and other relevant tests are obtained. The test was also put to trial in a pilot study, being applied to 150 subjects via phone surveys, home visiting, and geriatric clinic-it becomes particularly useful for assessing the social relationships in geriatric clinic use. The 4-item Geriatric Sociotype scale (SOCG-4) appears as a valid measurement instrument for use in the clinic and in other social care instances.


Subject(s)
COVID-19 , Loneliness , Aged , Humans , Interpersonal Relations , Pandemics , Pilot Projects , Reproducibility of Results , SARS-CoV-2 , Surveys and Questionnaires
2.
Int J Eat Disord ; 46(7): 690-2, 2013 Nov.
Article in English | MEDLINE | ID: mdl-23733370

ABSTRACT

OBJECTIVE: An excess of bulimia nervosa (BN) births during the fall has been recently reported, but this finding has not been yet adequately replicated. The purpose of our study was to evaluate the presence of a seasonal birth pattern in a representative clinical sample of women with BN. METHOD: We registered the month of birth of 216 female patients who fulfilled all the criteria for BN according to DSM-IV on admission to a specialized eating disorders service in Spain. RESULTS: Our analyses showed no significant variation in the season of birth of our BN sample when compared to a general population. DISCUSSION: Our data do not support the hypothesis of a season of birth bias in BN.


Subject(s)
Bulimia Nervosa/epidemiology , Seasons , Adult , Female , Humans , Spain/epidemiology
3.
J Infect Dis ; 179(6): 1587-90, 1999 Jun.
Article in English | MEDLINE | ID: mdl-10228090

ABSTRACT

This randomized, open-label clinical trial compared a fixed-dose combination of atovaquone and proguanil (n=55) with chloroquine (n=23) or a combination of chloroquine, sulfadoxine, and pyrimethamine (n=32) for treatment of acute falciparum malaria in the Philippines. Patients were hospitalized for 28 days to ensure medication compliance and prevent reinfection. Atovaquone-proguanil produced a significantly higher cure rate (100%) compared with that for chloroquine (30.4%; P<.0001) or chloroquine-sulfadoxine-pyrimethamine (87.5%; P<.05). Treatments did not differ significantly with respect to parasite clearance time (mean: 46.7 h for atovaquone-proguanil, 60.0 h for chloroquine, and 42.8 h for chloroquine-sulfadoxine-pyrimethamine) or fever clearance time (mean, 38.8, 46.8, and 34.5 h, respectively). Adverse events were typical of malaria symptoms; the most frequently reported events were vomiting (18% for atovaquone-proguanil, 17% for chloroquine, and 9% for chloroquine-sulfadoxine-pyrimethamine), abdominal pain (15%, 17%, and 3%, respectively), anorexia (11%, 13%, and 0%, respectively), and headache (6%, 17%, and 3%, respectively). Atovaquone-proguanil was well tolerated and more effective than chloroquine or chloroquine-sulfadoxine-pyrimethamine for treatment of multidrug-resistant falciparum malaria in the Philippines.


Subject(s)
Antimalarials/therapeutic use , Malaria, Falciparum/drug therapy , Naphthoquinones/therapeutic use , Proguanil/therapeutic use , Atovaquone , Chloroquine/therapeutic use , Drug Therapy, Combination , Folic Acid Antagonists/therapeutic use , Humans , Philippines , Pyrimethamine/therapeutic use , Sulfadoxine/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...